Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James J. McNally is active.

Publication


Featured researches published by James J. McNally.


Journal of Chromatography A | 1993

Analytical and preparative high-performance liquid chromatographic separation of thienopyran enantiomers

Charles J. Shaw; Pauline J. Sanfilippo; James J. McNally; Sung Ae Park; Jeffery B. Press

Abstract The analytical and preparative enantiomeric resolution of a racemic substituted thienopyran was obtained with a β-cyclodextrin bonded-phase column using isocratic conditions. Baseline separations were obtained with short run times. The analytical method is accurate, reliable and reproducible for measuring enantiomeric excess. A semi-preparative high-performance liquid chromatographic method was used to obtain the enantiomers for pharmacological testing prior to developing an asymmetric synthesis of RWJ 26629.


European Journal of Medicinal Chemistry | 1991

Thiophene systems. 12. Analogues of ketanserin and ritanserin as selective 5-HT2 antagonists

Jeffery B. Press; Rk Russell; James J. McNally; Ra Rampulla; Robert Falotico; C Scott; Jb Moore; Sj Offord; J Tobia

Abstract A series of thieno[3,2-d]-, [3,4-d]- and [2,3-d]pyrimidinedione derivatives was prepared with N-3 substitution containing the side chains of ketanserin and ritanserin. The best of these thiophene analogues were the isosteres of ketanserin which were up to 20-fold more potent than the standards in 5-HT2 binding assays. More importantly, in addition to their increased potency, these derivatives were more selective than the standards in that they had less affinity for 5-HT1A and α1 binding sites. This selectivity is especially noted as the ratio of α 1 5-HT 2 wherein the most interesting thiophene isostere (2) in this study had a binding selectivity > 12-fold of ketanserin or ritanserin.


Bioorganic & Medicinal Chemistry Letters | 2016

Tetrahydroindazole derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists.

Jay M. Matthews; James J. McNally; Peter J. Connolly; Mingde Xia; Bin Zhu; Shawn Black; Cailin Chen; Cuifen Hou; Yin Liang; Yuting Tang; Mark J. Macielag

A series of potent and receptor-selective cannabinoid-1 (CB1) receptor inverse agonists has been discovered. Peripheral selectivity of the compounds was assessed by a mouse tissue distribution study, in which the concentrations of a test compound in both plasma and brain were measured. A number of peripherally selective compounds have been identified through this process. Compound 2p was further evaluated in a 3-week efficacy study in the diet-induced obesity (DIO) mouse model. Beneficial effects on plasma glucose were observed from the compound-treated mice.


Bioorganic & Medicinal Chemistry | 1993

Novel thieno[2,3-b]- and [3,4-b]pyrans as potassium channel openers. Thiophene systems--XVII.

Jeffery B. Press; James J. McNally; Pauline J. Sanfilippo; Michael F. Addo; Deborah Loughney; Edward C. Giardino; Laurence B. Katz; Robert Falotico; Barbara J. Haertlein

The syntheses and antihypertensive activity of the thieno[3,4-b]pyran and thieno[2,3-b]pyran isosteres of the potassium channel opener (PCO) RWJ 26629 (+/- 2a) are reported. While the unsubstituted thiophene derivatives were active at 20 mg/kg, introduction of a strong electron withdrawing group in the 2-position of the thieno[3,2-b] series increased potency. Similar substitution on the thieno[3,4-b] series significantly lowered potency. Compounds 26 and 30 are approximately 5-fold more potent than the prototypic PCO cromakalim (+/- 1).


Journal of Medicinal Chemistry | 1988

Thiophene systems. 9. Thienopyrimidinedione derivatives as potential antihypertensive agents.

Ronald K. Russell; Jeffery B. Press; Richard Rampulla; James J. McNally; Robert Falotico; Joan Keiser; David A. Bright; Alfonso J. Tobia


Archive | 2008

Sulfonamides as trpm8 modulators

Shawn Branum; Raymond W. Colburn; Scott L. Dax; Christopher Flores; Michele C. Jetter; Yi Liu; Donald William Ludovici; Mark J. Macielag; Jay M. Matthews; James J. McNally; Laura M. Reaney; Ronald K. Russell; Ning Qin; Christopher A. Teleha; Kenneth M. Wells; Scott Youells; Mark A. Youngman


Bioorganic & Medicinal Chemistry Letters | 2012

The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.

Jay M. Matthews; Ning Qin; Raymond W. Colburn; Scott L. Dax; Michael J. Hawkins; James J. McNally; Laura Reany; Mark A. Youngman; Judith Baker; Tasha Hutchinson; Yi Liu; Mary Lou Lubin; Michael P. Neeper; Michael R. Brandt; Christopher M. Flores


Archive | 2005

Tricyclic delta-opioid modulators

Steven J. Coats; Scott L. Dax; Bart DeCorte; Li Liu; Mark McDonnell; James J. McNally


Journal of Organic Chemistry | 1992

Synthesis of N-thietan-3-yl-.alpha.-oxo nitrogen heterocycles from iminothioethers. A novel transformation

Jeffery B. Press; James J. McNally; Zoltan G. Hajos; Rebecca A. Sawyers


Archive | 2006

Tricyclic opioid modulators

Bart DeCorte; Li Liu; Mark McDonnell; James J. McNally

Collaboration


Dive into the James J. McNally's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Li Liu

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge